Fabtech Technologies Cleanrooms Secures ₹70.82 Crore in Orders for April 2026, Order Book Stands at ₹229.25 Crore
Fabtech Technologies Cleanrooms Limited secured consolidated orders worth ₹70.82 crore in April 2026, with Pharma contributing ₹40.01 crore and Renewable Energy ₹29.25 crore. The company's consolidated order book as of April 30, 2026, stood at ₹229.25 crore, led by Renewable Energy at ₹124.92 crore and Pharma at ₹89.06 crore. Orders under active consideration totalled ₹407.16 crore, with Renewable Energy and Pharma representing the largest opportunities. Key order wins during the month included a ₹31 crore Cleanroom Partitions order and a ₹29.25 crore HVAC LOI.

*this image is generated using AI for illustrative purposes only.
Fabtech Technologies Cleanrooms Limited has announced consolidated order bookings worth ₹70.82 crore for the month of April 2026, as disclosed under Regulation 30 on May 12, 2026. The Pharma sector led the order intake at ₹40.01 crore, followed by Renewable Energy at ₹29.25 crore and Others at ₹1.56 crore. From a business vertical perspective, Cleanroom Partitions contributed ₹40.01 crore and HVAC Systems accounted for ₹30.81 crore of the total bookings.
April 2026 Order Booking Breakdown
The following table summarises the sector-wise and vertical-wise distribution of orders secured during April 2026:
| Parameter: | Details |
|---|---|
| Total Orders (April 2026): | ₹70.82 crore |
| Pharma: | ₹40.01 crore |
| Renewable Energy: | ₹29.25 crore |
| Others: | ₹1.56 crore |
| Cleanroom Partitions: | ₹40.01 crore |
| HVAC Systems: | ₹30.81 crore |
During the month, the company secured notable individual orders, including a ₹31 crore order for Cleanroom Partitions and a ₹29.25 crore Letter of Intent (LOI) for HVAC systems, both from leading players in the healthcare and renewable energy sectors.
Consolidated Order Book as of April 30, 2026
As of April 30, 2026, Fabtech Technologies Cleanrooms' consolidated order book stood at ₹229.25 crore, spread across multiple sectors. The sector-wise composition is presented below:
| Sector: | Order Book Value |
|---|---|
| Renewable Energy: | ₹124.92 crore |
| Pharma: | ₹89.06 crore |
| Data Centres: | ₹4.91 crore |
| Semiconductors: | ₹0.50 crore |
| Others: | ₹9.86 crore |
| Total: | ₹229.25 crore |
Note: "Others" represents EV Batteries, FMCG, and miscellaneous industries.
Strong Pipeline with ₹407.16 Crore Under Active Consideration
Beyond the confirmed order book, orders under active consideration totalled ₹407.16 crore, indicating a robust business pipeline. The major opportunities under consideration are distributed as follows:
| Sector: | Value Under Consideration |
|---|---|
| Renewable Energy: | ₹198.52 crore |
| Pharma: | ₹100.13 crore |
| Data Centres: | ₹22.50 crore |
| Others: | ₹86.01 crore |
| Total: | ₹407.16 crore |
The company's order pipeline reflects significant activity across Renewable Energy and Pharma, which together account for the majority of both confirmed and prospective orders. The large-scale orders secured during April 2026 further demonstrate the company's capability to execute integrated cleanroom and HVAC projects across high-growth industries. This announcement was made by Executive Director Amjad Adam Arbani on behalf of Fabtech Technologies Cleanrooms Limited.
Historical Stock Returns for Fabtech Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.23% | -2.87% | +22.54% | -7.01% | -1.63% | +79.87% |
Given that Renewable Energy now dominates the confirmed order book at ₹124.92 crore and has ₹198.52 crore under active consideration, how might a slowdown in India's renewable energy capex cycle impact Fabtech's revenue visibility over the next 12–18 months?
With a conversion pipeline of ₹407.16 crore under active consideration against a confirmed order book of ₹229.25 crore, what win-rate trends and execution timelines should investors monitor to assess whether this pipeline translates into sustainable revenue growth?
As Data Centres represent only ₹4.91 crore in the confirmed order book despite ₹22.50 crore under consideration, could accelerating hyperscaler investments in India become a meaningful third growth vertical for Fabtech alongside Pharma and Renewable Energy?

































